Skip to main content

Labor Pain

1
Pipeline Programs
5
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Sharp Therapeutics
Sharp TherapeuticsPA - Pittsburgh
1 program
1
EphedrinePhase 41 trial
Active Trials
NCT02062801Completed710Est. Oct 2013
DyAnsys
DyAnsysCA - San Mateo
1 program
ANSiStimN/A1 trial
Active Trials
NCT02427139Unknown50Est. Sep 2016
Bilim Pharmaceuticals
Bilim PharmaceuticalsTurkey - Istanbul
1 program
Continuous Birth SupportN/A1 trial
Active Trials
NCT07563374Completed90Est. Mar 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Sharp TherapeuticsEphedrine
Bilim PharmaceuticalsContinuous Birth Support
DyAnsysANSiStim

Clinical Trials (3)

Total enrollment: 850 patients across 3 trials

Prophylactic Ephedrine and Combined Spinal Epidurals for Labor

Start: Jan 2012Est. completion: Oct 2013710 patients
Phase 4Completed
NCT07563374Bilim PharmaceuticalsContinuous Birth Support

Continuous Birth Support by Student Midwives and Labor Pain and Birth Satisfaction

Start: Dec 2024Est. completion: Mar 202590 patients
N/ACompleted

ANSiStim Study for Active Labor Pain

Start: Mar 2015Est. completion: Sep 201650 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.